Skip to main content

Saranac Partners Ltd

Position in GILD — Gilead Sciences, Inc.

CIK 2098745 LONDON, X0

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$440,966
+$323,306 QoQ
Shares Held
3,164
+198.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2025
2 quarters on record

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Saranac Partners Ltd holds $13,142,776 across 6 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $440,966 3,164
2025-09-30 $117,660 1,060